학술논문

Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
Document Type
Article
Source
In Lung Cancer August 2021 158:137-145
Subject
Language
ISSN
0169-5002